Mechanisms of resistance of bacteria causing ventilator-associated pneumonia

D. Szabó, Fernanda Silveira, Shigeki Fujitani, David L. Paterson

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

It is likely that the occurrence of antibiotic resistance in organisms that cause VAP will outstrip the ability of pharmaceutical manufacturers to develop new antibiotics active against these organisms. Bacteria can pass resistance mechanisms from one genus to another, and their rapid rate of multiplication allows for evolution of new resistance mechanisms within months of the first use of new antibiotics. These facts underscore the importance of prevention of inappropriate antibiotic use and the transfer of resistant organisms from one patient to another. Use of these strategies may be the only way to prevent a return to an era in which patients die because of the lack of availability of antibiotic therapy.

Original languageEnglish
Pages (from-to)75-79
Number of pages5
JournalClinics in Chest Medicine
Volume26
Issue number1
DOIs
Publication statusPublished - Mar 2005

Fingerprint

Ventilator-Associated Pneumonia
Anti-Bacterial Agents
Bacteria
Microbial Drug Resistance
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Mechanisms of resistance of bacteria causing ventilator-associated pneumonia. / Szabó, D.; Silveira, Fernanda; Fujitani, Shigeki; Paterson, David L.

In: Clinics in Chest Medicine, Vol. 26, No. 1, 03.2005, p. 75-79.

Research output: Contribution to journalArticle

Szabó, D. ; Silveira, Fernanda ; Fujitani, Shigeki ; Paterson, David L. / Mechanisms of resistance of bacteria causing ventilator-associated pneumonia. In: Clinics in Chest Medicine. 2005 ; Vol. 26, No. 1. pp. 75-79.
@article{ac8718f6506e4397989bf19bd4974cbf,
title = "Mechanisms of resistance of bacteria causing ventilator-associated pneumonia",
abstract = "It is likely that the occurrence of antibiotic resistance in organisms that cause VAP will outstrip the ability of pharmaceutical manufacturers to develop new antibiotics active against these organisms. Bacteria can pass resistance mechanisms from one genus to another, and their rapid rate of multiplication allows for evolution of new resistance mechanisms within months of the first use of new antibiotics. These facts underscore the importance of prevention of inappropriate antibiotic use and the transfer of resistant organisms from one patient to another. Use of these strategies may be the only way to prevent a return to an era in which patients die because of the lack of availability of antibiotic therapy.",
author = "D. Szab{\'o} and Fernanda Silveira and Shigeki Fujitani and Paterson, {David L.}",
year = "2005",
month = "3",
doi = "10.1016/j.ccm.2004.10.004",
language = "English",
volume = "26",
pages = "75--79",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Mechanisms of resistance of bacteria causing ventilator-associated pneumonia

AU - Szabó, D.

AU - Silveira, Fernanda

AU - Fujitani, Shigeki

AU - Paterson, David L.

PY - 2005/3

Y1 - 2005/3

N2 - It is likely that the occurrence of antibiotic resistance in organisms that cause VAP will outstrip the ability of pharmaceutical manufacturers to develop new antibiotics active against these organisms. Bacteria can pass resistance mechanisms from one genus to another, and their rapid rate of multiplication allows for evolution of new resistance mechanisms within months of the first use of new antibiotics. These facts underscore the importance of prevention of inappropriate antibiotic use and the transfer of resistant organisms from one patient to another. Use of these strategies may be the only way to prevent a return to an era in which patients die because of the lack of availability of antibiotic therapy.

AB - It is likely that the occurrence of antibiotic resistance in organisms that cause VAP will outstrip the ability of pharmaceutical manufacturers to develop new antibiotics active against these organisms. Bacteria can pass resistance mechanisms from one genus to another, and their rapid rate of multiplication allows for evolution of new resistance mechanisms within months of the first use of new antibiotics. These facts underscore the importance of prevention of inappropriate antibiotic use and the transfer of resistant organisms from one patient to another. Use of these strategies may be the only way to prevent a return to an era in which patients die because of the lack of availability of antibiotic therapy.

UR - http://www.scopus.com/inward/record.url?scp=15744387375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15744387375&partnerID=8YFLogxK

U2 - 10.1016/j.ccm.2004.10.004

DO - 10.1016/j.ccm.2004.10.004

M3 - Article

VL - 26

SP - 75

EP - 79

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

SN - 0272-5231

IS - 1

ER -